Bayesian Capital Management’s Hanesbrands HBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-35,400
Closed -$162K 648
2025
Q2
$162K Buy
+35,400
New +$171K 0.03% 477
2025
Q1
Sell
-29,900
Closed -$243K 752
2024
Q4
$243K Buy
+29,900
New +$235K 0.03% 533
2024
Q1
Sell
-34,093
Closed -$152K 908
2023
Q4
$152K Buy
+34,093
New +$139K 0.02% 635
2023
Q1
Sell
-22,000
Closed -$140K 916
2022
Q4
$140K Buy
+22,000
New +$151K 0.02% 642
2022
Q2
Sell
-58,800
Closed -$876K 902
2022
Q1
$876K Buy
+58,800
New +$925K 0.13% 234
2019
Q3
Sell
-66,900
Closed -$1.15M 591
2019
Q2
$1.15M Buy
66,900
+49,209
+278% +$848K 0.24% 120
2019
Q1
$316K Buy
+17,691
New +$294K 0.06% 378
2017
Q4
Sell
-50,600
Closed -$1.25M 614
2017
Q3
$1.25M Buy
+50,600
New +$1.21M 0.3% 99
2017
Q1
Sell
-79,800
Closed -$1.72M 520
2016
Q4
$1.72M Buy
+79,800
New +$1.91M 0.43% 36
2016
Q3
Sell
-23,006
Closed -$578K 414
2016
Q2
$578K Buy
+23,006
New +$627K 0.35% 95
2016
Q1
Sell
-13,900
Closed -$409K 386
2015
Q4
$409K Buy
+13,900
New +$417K 0.59% 46

Other funds holding HBI

Bayesian Capital Management's HBI Position: Q3 2025 in Review

Bayesian Capital Management sold out of Hanesbrands (HBI) in Q3 2025, closing a stake of 35,400 shares — an estimated $162K sold.

Bayesian Capital Management first reported a position in HBI in Q4 2015 and held it in 11 quarters. The position peaked at $1.72M in Q4 2016. 395 funds tracked by Wall St. Rank hold HBI as of Q3 2025.

  • Bayesian Capital Management reported no remaining Hanesbrands position as of Q3 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 35,400 Hanesbrands shares in Q3 2025, an estimated $162K.
  • Bayesian Capital Management first reported a position in Hanesbrands in Q4 2015 and held it in 11 quarters.
  • Bayesian Capital Management's Hanesbrands position peaked at $1.72M in Q4 2016.
  • 395 funds tracked by Wall St. Rank held Hanesbrands as of Q3 2025.

Based on Bayesian Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.